| Authors: |
Kazak L; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Chouchani ET; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Jedrychowski MP; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Erickson BK; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Shinoda K; Diabetes Center, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA., Cohen P; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Vetrivelan R; Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Lu GZ; Dana-Farber Cancer Institute, Boston, MA 02115, USA., Laznik-Bogoslavski D; Dana-Farber Cancer Institute, Boston, MA 02115, USA., Hasenfuss SC; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Kajimura S; Diabetes Center, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA., Gygi SP; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA., Spiegelman BM; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA. Electronic address: bruce_spiegelman@dfci.harvard.edu. |
